Drug Type Small molecule drug |
Synonyms DYP 688, DYP-688, DYP688 |
Target |
Mechanism GNA11 inhibitors(G protein subunit alpha 11 inhibitors), GNAQ inhibitors(G protein subunit alpha q inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Uveal Melanoma | Phase 2 | US | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | AU | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | FR | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | DE | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | NL | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | ES | 04 Jul 2022 | |
Uveal Melanoma | Phase 2 | CH | 04 Jul 2022 |